A Real-world Study: Efficacy and Safety of Anlotinib for Advanced Non-small Cell Lung Cancer(NSCLC)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Fengjun Cao
Shiyan Renmin Hospital
Principal Investigator - Guangqiao Qu
The Central Hospital of Xiao Gan
Principal Investigator - Guiming Chen
JingMen NO.2 People's Hospital
Principal Investigator - Li Kuang
Dongfeng Hospital Affiliated to Hubei Medical College
Principal Investigator - Qian Chu
Tongji Hospital
Principal Investigator - Ruizhi Ran
The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture
Principal Investigator - Tienan Yi
Xiangyang Central Hospital
Principal Investigator - Xinhua Xu
Yichang Central People's Hospital
Principal Investigator - Yang Fu
Xiangyang Hospital of Traditional Chinese Medicine
Principal Investigator - Yanhua Xu
Jingzhou Central Hospital
Principal Investigator - Yifa Yin
Yichang Second People's Hospital
Principal Investigator - Yinping Li
The Central Hospital of Xiao Gan
Principal Investigator - Youhong Dong
Xiangyang No.1 People's Hospital
Principal Investigator - Zhiguo Luo
Affiliated Taihe Hospital of Hubei University of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hubei Province
Wuhan, Hubei, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Jul 2019
- Primary completion
- 16 Jul 2022
- Completion
- 16 Jul 2022
- Last update posted
- 21 Oct 2022
- Registered enrollment
- 373
- Registry id
- NCT04871997
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.